Kyron.bio is a Paris-based biotechnology startup using synthetic biology to refine biologic drug design and improve the yield, activity, and stability of new therapies.
Subscribe to see Kyron.bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Kyron.bio is a biotechnology company headquartered in France. Its most recent funding round, Seed, raised $6M in May 2025. Xcout tracks 1 named person at Kyron.bio, including Emilia McLaughlin (Founder).
As of 16 November 2026. Source: Xcout Intel.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $6M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Kyron.bio's closest competitors — see the full list of competitors and alternatives →
Meddenovo Drug Design is a Lyon, France-based biotechnology company operating at the intersection of AI and life sciences to build advanced computational technologies for peptide drug discovery.
General Biotechnologies develops programmable synthetic biology platforms that use edible microbes to manufacture and deliver peptide therapeutics. The company primarily serves the pharmaceutical industry by reformulating discontinued peptide drugs into low-cost, needle-free oral medications and providing field-deployable biomanufacturing kits.
Founded in 2021 and located in Suresnes, France, Phagos is a biotechnology research company specializing in AI-native phage therapy. The firm creates personalized bacterial treatments as a sustainable alternative to antibiotics.
CytoReason provides a computational disease modeling platform designed for pharmaceutical R&D. The company's technology uses human data to help scientists and executives map disease mechanisms, prioritize drug portfolios, and predict treatment performance.
Serotiny is a synthetic biology company engineering multi-domain protein systems for cell therapies, including Chimeric Antigen Receptors (CARs). The firm operates within the biotechnology sector and has established biopharma technology agreements with partners like Twist Bioscience.
Constructive Bio is a biotechnology research company headquartered in Cambridge, United Kingdom, that focuses on designing and manufacturing proteins with non-canonical amino acids for new medicines and materials.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Kyron.bio? Suggest a correction · Work at Kyron.bio? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.